E
Agile Therapeutics, Inc. AGRX
OTC PK
Recommendation
Sell
Prev Close
$1.51
Volume
--
Avg Vol (90D)
112,515
Market Cap
$10.43M
Dividend & Yield
--
52-Week Range
$0.20 - $2.63
P/E (TTM)
--
EPS (TTM)
-$3.24
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Weak
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
$21.57M
EBITDA (TTM)
-$13.15M
EBIT (TTM)
-$13.56M
Net Income (TTM)
-$15.86M
Balance Sheet
Total Assets (Q)
$14.96M
Total Debt (Q)
$289.00K
Total Liabilities (Q)
$36.88M
Book Value Per Share (Q)
-$3.17
Cash Flow
Cash from Operations (TTM)
-$1.71M
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$1.77M
Net Change in Cash (TTM)
$64.00K
Filings
Filing Date
Monday, August 12, 2024
Period Date
Sunday, June 30, 2024
Next Filing
Week of Nov 4 and 8 (est)
Price History
Loading...
Beta
1.19
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
--
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Mar 26, 2024 - $0.20
52-week High
Sep 01, 2023 - $2.63
Valuation
Market Cap
$10.43M - Nano Cap
Enterprise Value
$7.87M
Price/Sales (TTM)
0.48
Price/Book (Q)
-0.48
Dividends and Shares
Shares Outstanding
6.86M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.agiletherapeutics.com
Phone Number
609 683 1880
Address
500 College Road East
Princeton, NJ 08540
Country
United States
Year Founded
1997
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Agile Therapeutics, Inc., a women's healthcare company, engages in the research, development, and commercialization of prescription contraceptive products for women in the United States. It... more
Weiss Ratings